Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer.
CONCLUSIONS: Although no significant links were found between GST polymorphism and treatment response, null genotypes of GSTM1, GSTT1 and 'G' allele of GSTP1 bring a higher risk of severe gastrointestinal toxicity due to chemoradiation therapy in cervical cancer.
PMID: 29909733 [PubMed - as supplied by publisher]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
More News: Antidoxidants | Biomedical Science | Cancer | Cancer & Oncology | Cervical Cancer | Gastroenterology | Genetics | Hematology | Laboratory Medicine | Science | Statistics | Toxicology | UK Health | Women